Evidence map›Paper›PMID 40955759›Full record

ArticleThe Journal of experimental biology2025

Is increasing the effective leg length of a human runner metabolically beneficial?

Montgomery Bertschy, Herlandt Lino, Laura Healey, Wouter Hoogkamer

Abstract read
In one paragraph

Article in The Journal of experimental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Montgomery BertschyIntegrative Locomotion Laboratory, Department of Kinesiology, University of Massachusetts, Amherst, MA 01003, USA.ORCID 0000-0002-4966-580X
Herlandt LinoIntegrative Locomotion Laboratory, Department of Kinesiology, University of Massachusetts, Amherst, MA 01003, USA.
Laura HealeyPUMA SE, Innovation, Somerville, MA 02155, USA.
Wouter HoogkamerIntegrative Locomotion Laboratory, Department of Kinesiology, University of Massachusetts, Amherst, MA 01003, USA.ORCID 0000-0003-0524-0196

Funding

PUMA SEUniversity of Massachusetts Amherst
6 · The paper itself

Abstract

The purpose of this study was to understand whether footwear midsole thickness can decrease the metabolic cost of running by increasing the effective leg length of a runner. We also sought to understand the effect of midsole compliance on these measures. Participants (N=16) ran on a treadmill at 14 km h-1 in four mass-matched shoe conditions: 30, 40 and 60 mm thickness of a firm midsole foam and 60 mm thickness of a compliant midsole foam. Over two testing sessions, we measured metabolic cost (two 5-min trials in each condition) and biomechanical measures (one 2-min trial in each condition). Increasing thickness in the firm midsole conditions increased effective leg length during early, mid and late stance (all P<0.001). However, metabolic cost increased (P=0.031). Changing material, from firm to compliant, decreased effective leg length during midstance (P<0.001), but not during early or late stance. This change in material also decreased metabolic cost (P<0.001). Results suggest that increasing midsole thickness can increase the effective leg length of a runner, but this isolated effect leads to increases in metabolic cost. In contrast, increasing midsole compliance, while keeping midsole thickness constant, leads to reductions in metabolic cost, agreeing with previous literature. We suggest that the performance benefits seen in advanced footwear technology are likely due to increased resilience of the midsole but not to increases in effective leg length from increased midsole thickness.

Indexed as

Energy MetabolismLegRunningShoesAdultBiomechanical PhenomenaFemaleHumansMaleYoung AdultAdvanced footwear technologyFootwearMetabolic costMidsole thicknessRunning

Identifiers

PMID40955759
PMCPMC12582409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.